Epirubicin/Cisplatin (EC) or EC plus Taxol (TEC) in a two weekly regimenin patients with advanced ovarian carcinoma (AOVCA)

J.B Vermorken, K. Hoekman, E.W. Muller, R.V.H.P. Huijskes, C.W. Burger, RHM Verheijen, P. Kenemans, H.M. Pinedo

Research output: Contribution to conferenceAbstractOther research output

Original languageEnglish
Publication statusPublished - 1995
Event5th International Congress on Anti-Cancer Chemotherapy - Paris, France
Duration: 3 Apr 1995 → …

Conference

Conference5th International Congress on Anti-Cancer Chemotherapy
Country/TerritoryFrance
CityParis
Period3/04/95 → …

Cite this